Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis

Detalhes bibliográficos
Autor(a) principal: Schriefer, Albert
Data de Publicação: 1995
Outros Autores: Barral, Aldina Maria Prado, Carvalho Filho, Edgar Marcelino, Barral Netto, Manoel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/7457
Resumo: Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório Integrado de Microbiologia e Imunorregulação. Salvador, BA, Brasil
id CRUZ_71f74ca79cbd16bbe208e5612c09ef94
oai_identifier_str oai:www.arca.fiocruz.br:icict/7457
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Schriefer, AlbertBarral, Aldina Maria PradoCarvalho Filho, Edgar MarcelinoBarral Netto, Manoel2014-03-26T18:42:12Z2014-03-26T18:42:12Z1995SCHRIEFER, A. et al. Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis. Clinical Experimental and Immunology, v. 102, n. 3, p. 535-540, 1995.0009-9104https://www.arca.fiocruz.br/handle/icict/7457engBlackwell ScienceSerum soluble markers in the evaluation of treatment in human visceral leishmaniasisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório Integrado de Microbiologia e Imunorregulação. Salvador, BA, BrasilUniversidade Federal da Bahia. Serviço de Imunologia. Hospital Universitário Prof. Edgard Santos. Salvador, BA, BrasilUniversidade Federal da Bahia. Serviço de Imunologia. Hospital Universitário Prof. Edgard Santos. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório Integrado de Microbiologia e Imunorregulação. Salvador, BA, BrasilVisceral leishmaniasis (VL) has a fatal course if not properly treated. Recovery from VL is linked to cellular immune response. Unresponsiveness to antimonial therapy reinforces the importance of determining parameters for treatment assessment. We analysed the pre- and post-treatment serum levels of soluble CD4 (sCD4), sCD8, sIL-2R, soluble intercellular adhesion molecule- I (sICAM- 1) and neopterin in groups of VL patients either responsive or not to standard antimonial therapy. Pretreatment serum levels of all markers except for sICAM-1 were significantly higher in VL patients than in healthy subjects from the same area (P < 0-05). sICAM-1 levels were similar in healthy controls and in VL patients refractory to antimonial therapy (P= 0 25), but significantly higher in patients responsive to treatment (P = 0-02). The comparison of pre- and post-treatment concentrations showed that all markers, except sCD4 and sICAM-1, presented a significant fall (P < 0 05) in patients responsive to antimonial therapy. However, only neopterin presented with levels compatible with those of healthy subjects at the end of treatment (P = 0 30). In refractory patients sICAM-1 presented with post-treatment levels significantly higher than the pretreatment determinations (P=0003), while sCD4 experienced a significant drop (P=0001). All markers displayed clearly distinct behaviour according to the patient's response to therapy. This makes all soluble molecules studied suitable for use as indicators of antimonial therapy response. Additionally the comparison of pretreatment levels of the markers between responders and refractory patients to antimonial therapy showed that serum concentrations of sIL-2R and sICAM-1 significantly differed among these two groups (P= 0 02 in each case), suggesting that they may be used in future as predictors of antimonial therapy response.Visceral leishmaniasisSoluble markersantimonialLeishmaniose Visceral/imunologiaAntígenos CD4/sangueAntígenos CD8/sangueAntimônio/uso terapêuticoBiopterina/análogos & derivadosBiopterina/sangueHumanosMolécula 1 de Adesão Intercelular/sangueLeishmaniose Visceral/quimioterapiaNeopterinaReceptores de Interleucina-2/análiseinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALSchriefer A Serum Soluble....pdfSchriefer A Serum Soluble....pdfapplication/pdf938558https://www.arca.fiocruz.br/bitstream/icict/7457/1/Schriefer%20A%20Serum%20Soluble....pdf2a23fd655aa0247dcb22e071e2e56851MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/7457/2/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD52TEXTSchriefer A Serum Soluble....pdf.txtSchriefer A Serum Soluble....pdf.txtExtracted texttext/plain26561https://www.arca.fiocruz.br/bitstream/icict/7457/5/Schriefer%20A%20Serum%20Soluble....pdf.txt7ecea75649d69226c5a88fbb7525de91MD55THUMBNAILSchriefer A Serum Soluble....pdf.jpgSchriefer A Serum Soluble....pdf.jpgGenerated Thumbnailimage/jpeg2358https://www.arca.fiocruz.br/bitstream/icict/7457/4/Schriefer%20A%20Serum%20Soluble....pdf.jpg2d582bf1819ec709b336cff753fc91d6MD54icict/74572023-03-15 14:33:23.2oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:23Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
title Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
spellingShingle Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
Schriefer, Albert
Visceral leishmaniasis
Soluble markers
antimonial
Leishmaniose Visceral/imunologia
Antígenos CD4/sangue
Antígenos CD8/sangue
Antimônio/uso terapêutico
Biopterina/análogos & derivados
Biopterina/sangue
Humanos
Molécula 1 de Adesão Intercelular/sangue
Leishmaniose Visceral/quimioterapia
Neopterina
Receptores de Interleucina-2/análise
title_short Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
title_full Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
title_fullStr Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
title_full_unstemmed Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
title_sort Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis
author Schriefer, Albert
author_facet Schriefer, Albert
Barral, Aldina Maria Prado
Carvalho Filho, Edgar Marcelino
Barral Netto, Manoel
author_role author
author2 Barral, Aldina Maria Prado
Carvalho Filho, Edgar Marcelino
Barral Netto, Manoel
author2_role author
author
author
dc.contributor.author.fl_str_mv Schriefer, Albert
Barral, Aldina Maria Prado
Carvalho Filho, Edgar Marcelino
Barral Netto, Manoel
dc.subject.en.pt_BR.fl_str_mv Visceral leishmaniasis
Soluble markers
antimonial
topic Visceral leishmaniasis
Soluble markers
antimonial
Leishmaniose Visceral/imunologia
Antígenos CD4/sangue
Antígenos CD8/sangue
Antimônio/uso terapêutico
Biopterina/análogos & derivados
Biopterina/sangue
Humanos
Molécula 1 de Adesão Intercelular/sangue
Leishmaniose Visceral/quimioterapia
Neopterina
Receptores de Interleucina-2/análise
dc.subject.decs.pt_BR.fl_str_mv Leishmaniose Visceral/imunologia
Antígenos CD4/sangue
Antígenos CD8/sangue
Antimônio/uso terapêutico
Biopterina/análogos & derivados
Biopterina/sangue
Humanos
Molécula 1 de Adesão Intercelular/sangue
Leishmaniose Visceral/quimioterapia
Neopterina
Receptores de Interleucina-2/análise
description Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório Integrado de Microbiologia e Imunorregulação. Salvador, BA, Brasil
publishDate 1995
dc.date.issued.fl_str_mv 1995
dc.date.accessioned.fl_str_mv 2014-03-26T18:42:12Z
dc.date.available.fl_str_mv 2014-03-26T18:42:12Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv SCHRIEFER, A. et al. Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis. Clinical Experimental and Immunology, v. 102, n. 3, p. 535-540, 1995.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/7457
dc.identifier.issn.none.fl_str_mv 0009-9104
identifier_str_mv SCHRIEFER, A. et al. Serum soluble markers in the evaluation of treatment in human visceral leishmaniasis. Clinical Experimental and Immunology, v. 102, n. 3, p. 535-540, 1995.
0009-9104
url https://www.arca.fiocruz.br/handle/icict/7457
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Blackwell Science
publisher.none.fl_str_mv Blackwell Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/7457/1/Schriefer%20A%20Serum%20Soluble....pdf
https://www.arca.fiocruz.br/bitstream/icict/7457/2/license.txt
https://www.arca.fiocruz.br/bitstream/icict/7457/5/Schriefer%20A%20Serum%20Soluble....pdf.txt
https://www.arca.fiocruz.br/bitstream/icict/7457/4/Schriefer%20A%20Serum%20Soluble....pdf.jpg
bitstream.checksum.fl_str_mv 2a23fd655aa0247dcb22e071e2e56851
7d48279ffeed55da8dfe2f8e81f3b81f
7ecea75649d69226c5a88fbb7525de91
2d582bf1819ec709b336cff753fc91d6
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324692248952832

Registros relacionados